Back

Association of ANGPTL3, ANGPTL4, and DOCK7 polymorphisms with lipid traits and long-term clinical outcomes in patients undergoing PCI

31 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Optimising outcomes in percutaneous coronary intervention: risk assessment, pharmacotherapy, and clinical insights Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Ying Song

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

5 More presentations in this session

Presentation thumbnail
CKD severity and high bleeding risk in patients undergoing PCI: stage-specific validation of modified ARC-HBR criteria
Doctor F. Di Muro (Salerno, IT)
Abstract
Presentation thumbnail
Potent P2Y12 inhibition with ticagrelor over clopidogrel in complex PCI: a systematic review and meta-analysis of clinical outcomes
Doctor A. Dos Santos Cleto (Indaiatuba, BR)
Abstract
Presentation thumbnail
Early bleeding risk prediction with the PRECISE-HBR score in PCI patients treated with cangrelor: the ICARUS registry
Doctor V. De Sio (Caserta, IT)
Abstract
Presentation thumbnail
Perfusion balloon prolonged inflation in lipid-rich coronary lesions and slow flow/no-reflow: NIRS-IVUS insights
Doctor S. Izumoto (Miyazaki, JP)
Abstract
Presentation thumbnail
Women demonstrate better one-year survival than men after microaxial pump-supported high-risk PCI
Associate Professor J. Sacha (Opole, PL)
Abstract

Access the full session

Session thumbnail
Optimising outcomes in percutaneous coronary intervention: risk assessment, pharmacotherapy, and clinical insights

The Event

Event poster

ESC Congress 2026

31 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Association between genetic polymorphisms in multiple thrombosis-related genes and long-term prognosis in coronary artery disease patients: a large-scale cohort study
1 September 2025
thumbnail
Congress Presentation
RNA interference targeting hepatic angiopoietin-like protein 3 results in prolonged reductions in serum triglyceride and non-HDL cholesterol concentrations: first human results with ARO-ANG3
25 August 2023
thumbnail
Congress Presentation
Triglyceride-associated markers and genetic variants of eNOS3 in the stratification of residual cardiorenal risk in patients with arterial hypertension and diabetic nephropathy
24 April 2026
thumbnail
Congress Presentation
Change in remnant lipid-inflammatory index predicts long-term outcomes in AMI survivors with achieved LDL-C targets
21 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources